Press Release Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR) Aug 21
Press Release Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR) Aug 21
Press Release Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update Aug 14
Press Release Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update Aug 12
Press Release Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026 Aug 4